China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.

Alphabet Inc. offshoot Wing, which just received an expanded certification to act as a small air carrier, is starting the nation’s inaugural delivery service via a small civilian aircraft with partners Walgreens and FedEx.

While most business leaders want to avoid a no-deal departure, continued uncertainty is not much better. With the cliff edge looming, and the prospect of another one in three months if the EU grants Parliament’s request for a further delay, collateral damage is mounting.

The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.

A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.

Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.

A draft executive order would target foreign shippers routing deliveries through the U.S. Postal Service — not the two-largest U.S. couriers United Parcel Service Inc. and FedEx Corp.

A Chinese outbreak of African swine fever that has killed millions of pigs in the country has also led to falling U.S. supplies of a widely used drug derived from the animals, the anti-clotting drug heparin.

The Trump administration sees the increasing use of Chinese-made active ingredients in drugs taken by U.S. troops and civilians as a national security risk.